Translational molecular imaging in exocrine pancreatic cancer

Bart Cornelissen, James C Knight, Somnath Mukherjee, Laura Evangelista, Catarina Xavier, Federico Caobelli, Silvana Del Vecchio, Latifa Rbah-Vidal, Jacques Barbet, Marion de Jong, Fijs W B van Leeuwen

Research output: Contribution to journalReview article

Abstract

Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.

Original languageEnglish
Pages (from-to)2442-2455
Number of pages14
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume45
Issue number13
DOIs
Publication statusPublished - Dec 2018

Fingerprint

Molecular Imaging
Pancreatic Neoplasms
Adenocarcinoma
Delayed Diagnosis
Radiotherapy
Drug Therapy
Therapeutics
Research

Cite this

Cornelissen, B., Knight, J. C., Mukherjee, S., Evangelista, L., Xavier, C., Caobelli, F., ... van Leeuwen, F. W. B. (2018). Translational molecular imaging in exocrine pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2442-2455. https://doi.org/10.1007/s00259-018-4146-5

Translational molecular imaging in exocrine pancreatic cancer. / Cornelissen, Bart; Knight, James C; Mukherjee, Somnath; Evangelista, Laura; Xavier, Catarina; Caobelli, Federico; Del Vecchio, Silvana; Rbah-Vidal, Latifa; Barbet, Jacques; de Jong, Marion; van Leeuwen, Fijs W B.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No. 13, 12.2018, p. 2442-2455.

Research output: Contribution to journalReview article

Cornelissen, B, Knight, JC, Mukherjee, S, Evangelista, L, Xavier, C, Caobelli, F, Del Vecchio, S, Rbah-Vidal, L, Barbet, J, de Jong, M & van Leeuwen, FWB 2018, 'Translational molecular imaging in exocrine pancreatic cancer', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 13, pp. 2442-2455. https://doi.org/10.1007/s00259-018-4146-5
Cornelissen, Bart ; Knight, James C ; Mukherjee, Somnath ; Evangelista, Laura ; Xavier, Catarina ; Caobelli, Federico ; Del Vecchio, Silvana ; Rbah-Vidal, Latifa ; Barbet, Jacques ; de Jong, Marion ; van Leeuwen, Fijs W B. / Translational molecular imaging in exocrine pancreatic cancer. In: European Journal of Nuclear Medicine and Molecular Imaging. 2018 ; Vol. 45, No. 13. pp. 2442-2455.
@article{fa7bd41cac384cc88713b8cabae07893,
title = "Translational molecular imaging in exocrine pancreatic cancer",
abstract = "Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95{\%} of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.",
author = "Bart Cornelissen and Knight, {James C} and Somnath Mukherjee and Laura Evangelista and Catarina Xavier and Federico Caobelli and {Del Vecchio}, Silvana and Latifa Rbah-Vidal and Jacques Barbet and {de Jong}, Marion and {van Leeuwen}, {Fijs W B}",
year = "2018",
month = "12",
doi = "10.1007/s00259-018-4146-5",
language = "English",
volume = "45",
pages = "2442--2455",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",
number = "13",

}

TY - JOUR

T1 - Translational molecular imaging in exocrine pancreatic cancer

AU - Cornelissen, Bart

AU - Knight, James C

AU - Mukherjee, Somnath

AU - Evangelista, Laura

AU - Xavier, Catarina

AU - Caobelli, Federico

AU - Del Vecchio, Silvana

AU - Rbah-Vidal, Latifa

AU - Barbet, Jacques

AU - de Jong, Marion

AU - van Leeuwen, Fijs W B

PY - 2018/12

Y1 - 2018/12

N2 - Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.

AB - Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.

U2 - 10.1007/s00259-018-4146-5

DO - 10.1007/s00259-018-4146-5

M3 - Review article

C2 - 30225616

VL - 45

SP - 2442

EP - 2455

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 13

ER -